Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
9 Months Ended
Sep. 30, 2017
Nov. 03, 2017
Document And Entity Information    
Entity Registrant Name ENDONOVO THERAPEUTICS, INC.  
Entity Central Index Key 0001528172  
Document Type 10-Q/A  
Document Period End Date Sep. 30, 2017  
Amendment Flag true  
Amendment Description We missed a typo with respect to the total share count on cover page causing a 302 million share differential. As such we are revising the cover page outstanding share amount to reflect the correct number of shares 305,274,764.  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   305,274,764
Trading Symbol ENDV  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2017